Advances in human mesenchymal stromal cell-based therapies - Towards an integrated biological and engineering approach

Stem Cell Research
Tom A WyrobnikMartina Micheletti

Abstract

Recent advances of stem cell-based therapies in clinical trials have raised the need for large-scale manufacturing platforms that can supply clinically relevant doses to meet an increasing demand. Promising results have been reported using stirred-tank bioreactors, where human Mesenchymal Stromal Cells (hMSCs) were cultured in suspension on microcarriers (MCs), although the formation of microcarrier-cell-aggregates might still limit mass transfer and determine a heterogeneous distribution of hMSCs. A variety of MCs, bioreactor-impeller configurations, and agitation conditions have been established in an attempt to overcome the trade-off of ensuring good suspension while keeping the stresses to a minimum. While understanding and controlling the fluid flow environment of bioreactors has been initially under-appreciated, it has recently gained in popularity in the mission of providing ideal culture environments across different scales. This review article aims to provide a comprehensive overview of how rigorous engineering characterisation studies improved the outcome of biological process development and scale-up efforts. Reconciling these two disciplines is crucial to propose tailored bioprocessing solutions that can provide imp...Continue Reading

References

Jan 29, 2009·Journal of Cell Science·Emily J ArnsdorfChristopher R Jacobs
Mar 14, 2009·Journal of Tissue Engineering and Regenerative Medicine·Maritie GrellierJoëlle Amédée
May 7, 2009·Acta Pharmacologica Sinica·Jian-de DongJian Zhang
Oct 21, 2009·Journal of Tissue Engineering and Regenerative Medicine·D SchopJ D de Bruijn
Sep 28, 2010·Regenerative Medicine·Gregory YourekGwendolen C Reilly
Apr 16, 2011·Tissue Engineering. Part B, Reviews·Melissa A KinneyTodd C McDevitt
May 13, 2011·Cytotechnology·C JusticeP Czermak
Jul 20, 2011·Biotechnology Letters·Christopher J HewittColin R Thomas
Mar 1, 2012·Biotechnology Progress·Caroline FerrariAnnie Marc
Mar 6, 2012·The International Journal of Artificial Organs·Christiane L ElsebergPeter Czermak
Jun 13, 2012·Journal of Tissue Engineering and Regenerative Medicine·Yifan YuanArindom Sen
Apr 24, 2013·Biotechnology Letters·Qasim A RafiqChristopher J Hewitt
Jan 15, 2014·Biotechnology and Bioengineering·Francisco Dos SantosJoaquim M S Cabral
May 28, 2014·Chemical Engineering Science·A O O OdeleyeM Micheletti
Jun 4, 2014·Biotechnology and Bioengineering·Julia HupfeldHeike Wegmeyer
Aug 21, 2014·Biotechnology Progress·Gerco van EikenhorstWilfried A M Bakker
Mar 3, 2015·Biotechnology and Bioengineering·Thomas R J HeathmanChristopher J Hewitt
Sep 20, 2015·Biochemical and Biophysical Research Communications·Kah Yong TanSteve Kah Weng Oh

❮ Previous
Next ❯

Citations

May 8, 2021·Biotechnology Advances·Charlotte MaillotEric Olmos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Bioreactors (ASM)

Bioreactors are important devices or systems that utilize living cells or enzymes for a chemical process. These devices carefully control and monitor the environment factors such as pH, nutrients level, and temperature, which can affect the yield in a given process. Discover the latest research here.